Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 20/20 | 0.83 |
| ▸ | CCR5 | P51681 | 15/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.68 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3748216 | 1.00 | CCR2 (0.83) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3748213 | 1.00 | CCR2 (0.83) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741659 | 0.92 | CCR2 (0.82) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741665 | 0.92 | CCR2 (0.82) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741668 | 0.92 | CCR2 (0.82) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3744295 | 0.91 | CCR2 (1.00) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3744291 | 0.91 | CCR2 (1.00) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3744301 | 0.91 | CCR2 (1.00) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741690 | 0.90 | CCR2 (0.72) | CCR2CCR5KCNH2CHRM2CHRM4 | |
| SCHEMBL3741687 | 0.90 | CCR2 (0.72) | CCR2CCR5KCNH2CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656345-B1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2013-10-16 | — | — | EP | claimed |
| US-7829571-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-11-09 | — | — | US | disclosed |